Justin Thompson, MD
Pain Medicine · Dallas, TXNPI 1275851719
Payments from drug & device makers
Across 454 payments — averaging $98.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Foundation Fusion Solutions, LLC$16K
- Medtronic$8K
- Boston Scientific$3K
- Abbott$3K
- MML US, Inc.$2K
- Saluda Medical Americas, Inc.$2K
- plus $10K from 26 others
What the payments were for
- Consulting fees$13,00029%
- Speaking & faculty fees$1,8004%
- Travel & lodging$9,21721%
- Food & beverage$17,95140%
- Education$2,2615%
- Entertainment$3071%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Foundation Fusion Solutions, LLC | 31 | $15,745 |
| Medtronic(2 entities) | 115 | $7,626 |
| Boston Scientific | 129 | $3,032 |
| Abbott | 37 | $2,941 |
| MML US, Inc. | 15 | $2,450 |
| Saluda Medical Americas, Inc. | 6 | $2,316 |
| Nevro Corp. | 11 | $2,199 |
| Spinal Simplicity, LLC | 3 | $1,741 |
| Painteq LLC | 14 | $1,239 |
| Relievant Medsystems, Inc. | 10 | $1,064 |
| Vertiflex, Inc. | 12 | $1,044 |
| AbbVie(2 entities) | 27 | $597 |
| SPR Therapeutics, Inc | 5 | $451 |
| Arthrex | 3 | $288 |
| Indivior Inc. | 6 | $276 |
| Stimwave Technologies Incorporated | 3 | $233 |
| Orthofix Medical, Inc. | 4 | $223 |
| Vertos Medical, Inc. | 1 | $156 |
| Flowonix Medical Incorporated | 1 | $153 |
| Curonix LLC | 4 | $147 |
| Pylant Medical | 1 | $127 |
| Microport Orthopedics Inc | 1 | $105 |
| Scilex Pharmaceuticals Inc. | 2 | $104 |
| GE HealthCare | 1 | $77 |
| Pfizer | 3 | $43 |
| Nalu Medical, Inc. | 2 | $41 |
| Hikma Pharmaceuticals USA | 2 | $34 |
| Vertex | 1 | $19 |
| Globus Medical | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Theragen, Inc. | 1 | $15 |
| Acera Surgical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$3,324
- INTELLIS ADAPTIVESTIM$2,538
- ReActiv8$2,191
- Evoke SCS$2,168
- Senza$1,800
- HA MINUTEMAN G3-R$1,737
- PAINTEQ$950
- PROCLAIM$832
- SYNCHROMEDII$786
- Superion ISS$758
- VANTA ADAPTIVESTIM$583
- KYPHON EXPRESS II KYPHOPAK TRAY$529
- SYNCHROMED$502
- Axium$476
- WAVEWRITER ALPHA$429
- Proclaim Family of SCS IPGs$372
- SPRINT PNS System$354
- ADAPTIVESTIM$246
- CFNS StimQ Peripheral Nerve StimulatorSystem$189
- SCS FreedonSpinal Cord Stimulator$189
How this compares
$44,535 in reported general payments places this provider in the 90th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,042 | $41,703 |
| Xtampza ErOxycodone Myristate | 35 | $20,460 |
| Pregabalin | 333 | $14,230 |
| BelbucaBuprenorphine Hcl | 16 | $11,667 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 150 | $6,843 |
| Lidocaine | 62 | $6,833 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 45 | $5,733 |
| Oxycodone Hcl | 232 | $5,282 |
| Hysingla ErHydrocodone Bitartrate | 12 | $4,471 |
| Gabapentin | 360 | $3,765 |
| Fentanyl | 38 | $3,749 |
| Buprenorphine Hcl | 39 | $3,318 |
| Tizanidine Hcl | 277 | $3,268 |
| Cyclobenzaprine Hcl | 284 | $3,017 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 98 | $2,675 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USABuprenorphine-Naloxone, Buprenorphine Hcl | $34 | $9,05184 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 583 pain medicine providers in Texas.
Other pain medicine in Dallas
- Muhammad ZulqarnainDallas$556K
- Amol PatwardhanDallas$177K
- Demaceo HowardDallas$39K
- Aaron CalodneyTyler$3M
- Mitchell EngleHouston$1.5M
- Melissa MurphyGrapevine$711K
- Shiraz YazdaniLubbock$632K
- Daniel PakHouston$460K
- Marvin ChangSugar Land$306K
- David LeimanHouston$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.